Clinical Trial Update: A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study of AV-380 in cancer patients with cachexia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cachexia

Drugs mentioned

• AV-380

Snippet

Sponsor: AVEO Pharmaceuticals, Inc. | Conditions: Cachexia | Phase 1 | Status: RECRUITING